Abstract:To investigate the biophysical mechanisms that regulate the spatial dynamics of blood coagulation, we have developed a set of microfluidic tools that allow analysis and perturbation of blood coagulation on the micrometer scale with precise control of fluid flow, geometry, and surface chemistry. Physiological coagulation occurs in a localized manner; specifically, coagulation is believed to occur exclusively at regions of substantial vascular damage and does not spread throughout the entire vascular system. In vitro analysis and characterization of these spatial dynamics requires the ability to reproduce and perturb this system, an ability that is not provided by the mixed reactor systems commonly used for in vitro studies of blood coagulation. We developed microfluidic devices with micrometer-scale channels and methods to coat these channels with various phospholipids, including components of the blood coagulation network such as thrombomodulin and tissue factor, to reproduce in vitro the geometry and surface chemistry of blood vessels in vitro. In a microfluidic device with channels coated with phospholipids and thrombomodulin, we demonstrated that clots propagate in a wave-like fashion with a constant velocity in the absence of flow. We also showed that propagation of coagulation from an occluded channel to a channel with flowing blood plasma can be regulated by the geometry of the junction and the shear rate in the channel with flowing plasma. We also developed microfluidic tools to probe the spatial dynamics of initiation of clotting by patterning surfaces with tissue factor reconstituted into phospholipids bilayers. When human plasma or whole blood was exposed to these surfaces in a microfluidic device, clotting occurred only on patches of tissue factor larger than a threshold size. This threshold patch size is controlled by the rate of activation of clotting factors at the patch and the rate of transport of activated factors off the patch. These results suggest a mechanism for how tissue factor can circulate in blood without causing clotting, and how small regions of vascular damage can exist without causing clotting. These results also suggest new biophysical mechanisms that may control interactions between the coagulation cascade and bacterial surfaces.

Coagulation System/Physiology

Structure-Function Relationships of Human Coagulation Proteins

Developmental Hemostasis: The Evolution of our Coagulation System

Blood Coagulation: Hemostasis and Thrombin Regulation

Mechanisms Involved in Regulation of Blood Coagulation: History of Research and Perspectives

Back to basics: the coagulation pathway

New Insights into How Blood Clots: Implications for the Use of APTT and PT as Coagulation Screening Tests and in Monitoring of Anticoagulant Therapy

Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation

Routine Coagulation

Endothelial cells and coagulation

Coagulation in Lymphatic System

New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology

Complement-coagulation connections

Physical forces regulating hemostasis and thrombosis: Vessels, cells, and molecules in illustrated review

Disseminated Intravascular Coagulation: Objective Clinical and Laboratory Diagnosis, Treatment, and Assessment of Therapeutic Response

401 Detecting Hypofibrinolysis in Clinical Coagulation Testing

An Update on Safe Anticoagulation.

Microfluidic Tools to Probe the Spatial Dynamics of Coagulation.

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope

Disseminated Intravascular Coagulation: Pathophysiological Mechanisms and Manifestations